These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

34 related items for PubMed ID: 22883471

  • 1. Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.
    O'Byrne ML, Cohen MS.
    Congenit Heart Dis; 2013; 8(5):E130-3. PubMed ID: 22883471
    [Abstract] [Full Text] [Related]

  • 2. An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children.
    Conte C, Sogni F, Rigante D, Esposito S.
    Diagnostics (Basel); 2023 Apr 17; 13(8):. PubMed ID: 37189542
    [Abstract] [Full Text] [Related]

  • 3. [Vasculitides and eosinophilic pulmonary diseases].
    Kroegel C, Foerster M, Quickert S, Slevogt H, Neumann T.
    Z Rheumatol; 2018 Dec 17; 77(10):907-922. PubMed ID: 30367242
    [Abstract] [Full Text] [Related]

  • 4. [Vasculitides and eosinophilic pulmonary diseases].
    Kroegel C, Foerster M, Quickert S, Slevogt H, Neumann T.
    Internist (Berl); 2018 Sep 17; 59(9):898-910. PubMed ID: 30140942
    [Abstract] [Full Text] [Related]

  • 5. Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady.
    Johnson RM, Bergmann KR, Manaloor JJ, Yu X, Slaven JE, Kharbanda AB.
    Open Forum Infect Dis; 2016 Sep 17; 3(3):ofw160. PubMed ID: 27704015
    [Abstract] [Full Text] [Related]

  • 6. Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.
    O'Byrne ML, Cohen MS.
    Congenit Heart Dis; 2013 Sep 17; 8(5):E130-3. PubMed ID: 22883471
    [Abstract] [Full Text] [Related]

  • 7. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar 17; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

  • 8. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T, Fujita A, Takeuchi S, Muto S, Soma Y.
    J Am Acad Dermatol; 2009 Jan 17; 60(1):146-9. PubMed ID: 19103366
    [Abstract] [Full Text] [Related]

  • 9. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC, Wang CL, Wang L, Yu HR, Yang KD.
    Pediatr Allergy Immunol; 2008 Mar 17; 19(2):184-5. PubMed ID: 18257906
    [No Abstract] [Full Text] [Related]

  • 10. Kawasaki disease: a dangerous acute childhood illness.
    Rubin B, Cotton DM.
    Nurse Pract; 1998 Feb 17; 23(2):34, 37-8, 44-8. PubMed ID: 9513217
    [Abstract] [Full Text] [Related]

  • 11. A patient with kawasaki disease showing severe tricuspid regurgitation and left ventricular dysfunction in the acute phase.
    Shinohara T, Tanihira Y.
    Pediatr Cardiol; 2003 Feb 17; 24(1):60-3. PubMed ID: 12574980
    [Abstract] [Full Text] [Related]

  • 12. Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.
    O'Byrne ML, Cohen MS.
    Congenit Heart Dis; 2013 Feb 17; 8(5):E130-3. PubMed ID: 22883471
    [Abstract] [Full Text] [Related]

  • 13. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar 17; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T, Fujita A, Takeuchi S, Muto S, Soma Y.
    J Am Acad Dermatol; 2009 Jan 17; 60(1):146-9. PubMed ID: 19103366
    [Abstract] [Full Text] [Related]

  • 15. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC, Wang CL, Wang L, Yu HR, Yang KD.
    Pediatr Allergy Immunol; 2008 Mar 17; 19(2):184-5. PubMed ID: 18257906
    [No Abstract] [Full Text] [Related]

  • 16. Intestinal ischaemia as a severe presentation of Kawasaki disease leading to short-bowel syndrome.
    Godart F, Bakhti OM, Bonnevalle M.
    Cardiol Young; 2014 Jun 17; 24(3):567-70. PubMed ID: 23962748
    [Abstract] [Full Text] [Related]

  • 17. Hair loss as a sign of Kawasaki disease.
    Nabavizadeh SH, Safari M, Amin R.
    Iran J Allergy Asthma Immunol; 2006 Dec 17; 5(4):199-200. PubMed ID: 17237574
    [Abstract] [Full Text] [Related]

  • 18. Marked eosinophilia in a patient with history of severe atypical Kawasaki disease.
    O'Byrne ML, Cohen MS.
    Congenit Heart Dis; 2013 Dec 17; 8(5):E130-3. PubMed ID: 22883471
    [Abstract] [Full Text] [Related]

  • 19. Kawasaki disease: a dangerous acute childhood illness.
    Rubin B, Cotton DM.
    Nurse Pract; 1998 Feb 17; 23(2):34, 37-8, 44-8. PubMed ID: 9513217
    [Abstract] [Full Text] [Related]

  • 20. A patient with kawasaki disease showing severe tricuspid regurgitation and left ventricular dysfunction in the acute phase.
    Shinohara T, Tanihira Y.
    Pediatr Cardiol; 2003 Feb 17; 24(1):60-3. PubMed ID: 12574980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.